000 | 01200 a2200361 4500 | ||
---|---|---|---|
005 | 20250515232448.0 | ||
264 | 0 | _c20110203 | |
008 | 201102s 0 0 eng d | ||
022 | _a1750-7448 | ||
024 | 7 |
_a10.2217/imt.09.66 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMarkman, Ben | |
245 | 0 | 0 |
_aNew trends in epidermal growth factor receptor-directed monoclonal antibodies. _h[electronic resource] |
260 |
_bImmunotherapy _cNov 2009 |
||
300 |
_a965-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
650 | 0 | 4 | _aCetuximab |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aNeoplasms _ximmunology |
650 | 0 | 4 | _aPanitumumab |
650 | 0 | 4 | _aProtein Engineering |
650 | 0 | 4 | _aSignal Transduction |
700 | 1 | _aCapdevila, Jaume | |
700 | 1 | _aElez, Elena | |
700 | 1 | _aTabernero, Josep | |
773 | 0 |
_tImmunotherapy _gvol. 1 _gno. 6 _gp. 965-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/imt.09.66 _zAvailable from publisher's website |
999 |
_c19978478 _d19978478 |